Alemtuzumab (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Alemtuzumab" in Italian language version.

refsWebsite

Global rank Italian rank

4doi.org

2^nd place

7^th place

3nih.gov

4^th place

9^th place

2sagepub.com

731^st place

1,032^nd place

2europa.eu

68^th place

57^th place

1drugs.com

399^th place

1,563^rd place

1pharmatimes.com

low place

1doai.io

low place

3,405^th place

1pharmastar.it

low place

7,927^th place

1aifa.gov.it

low place

6,468^th place

1fda.gov

447^th place

644^th place

1thelancet.com

2,393^rd place

2,216^th place

1web.archive.org

1^st place

1medicines.org.uk

3,823^rd place

low place

1ucl.ac.uk

1,306^th place

3,226^th place

aifa.gov.it

Nota informativa importante su mabcampath alemtuzumab, in http://www.aifa.gov.it/content/nota-informativa-importante-su-mabcampath-alemtuzumab-10082012.

doai.io

Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-7. DOI: 10.1038/332323a0 PMID 3127726.

doi.org

dx.doi.org

Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-7. DOI: 10.1038/332323a0 PMID 3127726.
(EN) Christina J. Azevedo, Christen Kutz e Amy Dix, Intracerebral haemorrhage during alemtuzumab administration, in The Lancet Neurology, vol. 18, n. 4, 1º aprile 2019, pp. 329–331, DOI:10.1016/S1474-4422(19)30076-6. URL consultato il 30 gennaio 2020.
(EN) Marwan Sheikh-Taha e Lourdes C Corman, Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis, in Multiple Sclerosis Journal, vol. 23, n. 6, 2017-02, pp. 872–874, DOI:10.1177/1352458517694431. URL consultato il 30 gennaio 2020.
(EN) Marinella Clerico, Stefania De Mercanti e Carlo Alberto Artusi, Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab, in Multiple Sclerosis Journal, vol. 23, n. 6, 2017-02, pp. 874–876, DOI:10.1177/1352458516688350. URL consultato il 30 gennaio 2020.

drugs.com

(EN) Alemtuzumab Monograph for Professionals, su Drugs.com. URL consultato il 30 gennaio 2020.

europa.eu

ec.europa.eu

Scheda Tecnica (Riassunto delle Caratteristiche del Prodotto) Lemtrada, EMA (PDF), su ec.europa.eu.

ema.europa.eu

(EN) Estela Miranda FRANCISCO, Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2019, su European Medicines Agency, 11 aprile 2019. URL consultato il 30 gennaio 2020.

fda.gov

FDA Drug Safety Communication.

medicines.org.uk

Home - electronic medicines compendium (emc), su medicines.org.uk. URL consultato il 30 gennaio 2020.

nih.gov

ncbi.nlm.nih.gov

Hale G, Bright S, Chumbley G, Hoang T, Metcalf D, Munro AJ, Waldmann H. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood 1983;62:873-82. PMID 6349718.
Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-7. DOI: 10.1038/332323a0 PMID 3127726.

pubmed.ncbi.nlm.nih.gov

(EN) Zhang J, Shi S, Zhang Y, Luo J, Xiao Y, Meng L, Alemtuzumab Versus Interferon Beta 1a for Relapsing-Remitting Multiple Sclerosis ^{[collegamento interrotto]}, su The Cochrane database of systematic reviews, 27 novembre 2017. URL consultato il 30 gennaio 2020.

pharmastar.it

PHARMASTAR :: Sanofi compra Genzyme, affare da 20 miliardi di dollari, su pharmastar.it. URL consultato il 16 febbraio 2011.

pharmatimes.com

(EN) Selina McKee, Sanofi withdraws Campath in US and EU, su PharmaTimes, 21 agosto 2012. URL consultato il 30 gennaio 2020.

sagepub.com

journals.sagepub.com

(EN) Marwan Sheikh-Taha e Lourdes C Corman, Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis, in Multiple Sclerosis Journal, vol. 23, n. 6, 2017-02, pp. 872–874, DOI:10.1177/1352458517694431. URL consultato il 30 gennaio 2020.
(EN) Marinella Clerico, Stefania De Mercanti e Carlo Alberto Artusi, Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab, in Multiple Sclerosis Journal, vol. 23, n. 6, 2017-02, pp. 874–876, DOI:10.1177/1352458516688350. URL consultato il 30 gennaio 2020.

thelancet.com

(EN) Christina J. Azevedo, Christen Kutz e Amy Dix, Intracerebral haemorrhage during alemtuzumab administration, in The Lancet Neurology, vol. 18, n. 4, 1º aprile 2019, pp. 329–331, DOI:10.1016/S1474-4422(19)30076-6. URL consultato il 30 gennaio 2020.

ucl.ac.uk

discovery.ucl.ac.uk

New cases of norcardial infection and cytomegalovirus syndrome (PDF).

web.archive.org

LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc), su medicines.org.uk. URL consultato il 30 gennaio 2020 (archiviato dall'url originale il 6 maggio 2021).